Isoniazid and Thalidomide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Isoniazid (isoniazid) and Thalidomide (thalidomide). Common drug interactions include drug ineffective among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Isoniazid and Thalidomide. It is created by eHealthMe based on reports of 49 people who take the same drugs from the FDA, and is updated regularly.

What is Isoniazid?

Isoniazid has active ingredients of isoniazid. It is often used in tuberculosis. eHealthMe is studying from 20,174 Isoniazid users. Check the latest studies of Isoniazid.

What is Thalidomide?

Thalidomide has active ingredients of thalidomide. eHealthMe is studying from 16,473 Thalidomide users. Check the latest studies of Thalidomide.

On Jul, 26, 2026

49 people who take Isoniazid and Thalidomide together, and have interactions are studied.

Isoniazid and Thalidomide drug interactions.

What are the common drug interactions of Isoniazid and Thalidomide, by gender? *:

female:

Drug ineffective
Bradycardia (abnormally slow heart action)
Hepatitis (inflammation of the liver)
Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
Arteritis (inflammation of the walls of arteries)
Carotid artery stenosis (narrowing of carotid artery)
Hemiparesis (weakness on one side of the body)
Interstitial lung disease
Tuberculosis of central nervous system (a bacterial infection of brain and spinal cord by mycobacterium tuberculosis)
Vasculitis (inflammation of a blood vessel or blood vessels)

male:

Drug ineffective
Drug resistance (reduction in effectiveness of a drug)
Retroperitoneal haemorrhage (bleeding between the peritoneum and the posterior abdominal wall)
Neuropathy peripheral (surface nerve damage)
Blood uric acid increased
Disseminated tuberculosis
Plasma cell myeloma (cancer that begins in plasma cells)
Death
Ischaemia (insufficient supply of blood to an organ, usually due to a blocked artery)
Therapeutic response unexpected

What are the common drug interactions of Isoniazid and Thalidomide, by age (0-1 to 60+)? *:

0-1:

Cerebral infarction (less blood supply to brain resulting tissue damage)

2-9:

Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
Arteritis (inflammation of the walls of arteries)
Carotid artery stenosis (narrowing of carotid artery)
Hemiparesis (weakness on one side of the body)
Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
Thalamic infarction (tissue death of thalamus part of brain)

10-19:

n/a

20-29:

n/a

30-39:

Drug resistance (reduction in effectiveness of a drug)
Somnolence (a state of near-sleep, a strong desire for sleep)
Drug ineffective
Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
Hydrocephalus (water on the brain)
Thalamic infarction (tissue death of thalamus part of brain)
Vasculitis (inflammation of a blood vessel or blood vessels)
Cardiac arrest
Tuberculosis of central nervous system (a bacterial infection of brain and spinal cord by mycobacterium tuberculosis)
Blood uric acid increased

40-49:

Drug ineffective
Bradycardia (abnormally slow heart action)
Hepatitis (inflammation of the liver)
Tuberculosis of central nervous system (a bacterial infection of brain and spinal cord by mycobacterium tuberculosis)
Vasculitis (inflammation of a blood vessel or blood vessels)
Paradoxical drug reaction
Transaminases increased
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Cushingoid (obesity and weakening of the muscles)
Depressed mood

50-59:

Drug ineffective

60+:

Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Retroperitoneal haemorrhage (bleeding between the peritoneum and the posterior abdominal wall)
Tuberculosis gastrointestinal (a bacterial infection of digestive tract by mycobacterium tuberculosis)
Drug ineffective
Interstitial lung disease
Disseminated tuberculosis
Plasma cell myeloma (cancer that begins in plasma cells)
Stress cardiomyopathy (stress-induced chronic disease of the heart muscle)
Anal abscess
Pneumonia

What are the existing conditions these people have? *

Tuberculosis Of Central Nervous System (a bacterial infection of brain and spinal cord by mycobacterium tuberculosis): 23 people, 46.94%
Disseminated Tuberculosis: 20 people, 40.82%
Multiple Myeloma (cancer of the plasma cells): 11 people, 22.45%
Meningitis Tuberculous (a bacterial infection of the membranes covering the brain and spinal cord (meninges)): 7 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Isoniazid and Thalidomide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously